Skip to Main Content
Prescriber's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Respiratory & Allergy
  4. COPD

COPD

  • Allergic Reactions (120)
  • Allergic Rhinitis (53)
  • Asthma (161)
  • Autoimmune Disorders (3)
  • COPD (129)
    • Immunizations (33)
    • Interactions (10)
    • Treatment (108)
  • Cystic Fibrosis (3)
  • Ear Health (13)
  • Ear, Nose & Throat (35)
  • E-Cigarettes (1)
  • Immunology (9)
  • Inhalers (25)
  • Other (16)
  • Otolaryngology (23)
  • Pulmonary (21)
  • Resources (277)
  • Respiratory Infections (369)
  • Sleep Apnea (12)
  • Smoking (19)
  • Smoking Cessation (116)
121 - 129 of 129 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Global Strategy for Diagnosis, Management, and Prevention of COPD (December 2010) March 2008
Commentary: Advair (Salmeterol/Fluticasone) vs Spiriva (Tiotropium) for COPD March 2008
Other: How do HFA Inhalers Compare to CFC Inhalers? November 2007
Article: Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing July 2007
Commentary: High-Dose Advair for COPD April 2007
Guideline: Global Strategy for Diagnosis, Management, and Prevention of COPD (2011) April 2007
Article: risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID December 2006
Other: Tips for Correct Use of Metered Dose Inhalers (MDIs) October 2006
Article: Are all inhalation devices equally effective March 2005
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved